HIF1A and neoplasm: Even though HIF-1α is exclusively localized in the nucleus of most cancer cells, it will be interesting to examine whether the ability of DAPK to promote HIF-1α degradation in the cytoplasm also contributes to the tumour suppressing function of DAPK in selective cancer types.